Repurposing of FDA-approved drugs using a high-throughput screening reveals colchicine as an anti-atypical teratoid/rhabdoid tumor (AT/RT) agent :: Samaggi Abstract Competition 2022 :: pretalx

Repurposing of FDA-approved drugs using a high-throughput screening reveals colchicine as an anti-atypical teratoid/rhabdoid tumor (AT/RT) agent
.ical

2022-02-19 14:30–15:10, E-poster Breakout Room

<Speaker requests that their abstract not be made public.>

Phongthon Kanjanasirirat